Post-approval studies (Phase 4)UnknownNCT05298475
What this trial is testing
Low-dose PCSK9 Inhibitor Combined With Stains on Serum Lipids in Chinese Population With Acute Coronary Syndrome
Who this might be right for
Acute Coronary Syndrome
The First Affiliated Hospital with Nanjing Medical University 100